Direxion Daily Mid Cap Bull 3X ETF (NYSEARCA:MIDU) Sees Large Decline in Short Interest
by Mitch Edgeman · The Markets DailyDirexion Daily Mid Cap Bull 3X ETF (NYSEARCA:MIDU – Get Free Report) was the recipient of a large decrease in short interest in the month of October. As of October 15th, there was short interest totaling 13,487 shares, a decrease of 39.0% from the September 30th total of 22,122 shares. Based on an average daily volume of 26,486 shares, the short-interest ratio is currently 0.5 days. Approximately 1.3% of the shares of the company are sold short.
Direxion Daily Mid Cap Bull 3X ETF Price Performance
Shares of NYSEARCA:MIDU traded up $1.12 during mid-day trading on Monday, reaching $63.21. 24,351 shares of the company traded hands, compared to its average volume of 29,758. The firm has a market cap of $63.21 million, a PE ratio of 18.98 and a beta of 3.07. Direxion Daily Mid Cap Bull 3X ETF has a 52 week low of $42.74 and a 52 week high of $77.88. The company’s 50 day moving average price is $63.76 and its 200-day moving average price is $64.21.
Institutional Investors Weigh In On Direxion Daily Mid Cap Bull 3X ETF
A hedge fund recently bought a new stake in Direxion Daily Mid Cap Bull 3X ETF stock. Toth Financial Advisory Corp acquired a new position in Direxion Daily Mid Cap Bull 3X ETF (NYSEARCA:MIDU – Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 1,219 shares of the company’s stock, valued at approximately $72,000. Toth Financial Advisory Corp owned 0.12% of Direxion Daily Mid Cap Bull 3X ETF as of its most recent filing with the Securities and Exchange Commission (SEC).
About Direxion Daily Mid Cap Bull 3X ETF
The Direxion Daily Mid Cap Bull 3X Shares (MIDU) is an exchange-traded fund that is based on the S&P Mid Cap 400 index. The fund provides 3x leveraged exposure to a market cap-weighted index of US mid-cap companies. MIDU was launched on Jan 8, 2009 and is managed by Direxion.
Read More
- Five stocks we like better than Direxion Daily Mid Cap Bull 3X ETF
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid